Large meals can also increase nausea and bloating
Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic testing
Diabetes & Endocrinology, 10(9), 623633
This bleeding typically decreases as the body adjusts to the hormones
These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Dyspepsia (indigestion) These gastrointestinal symptoms typically occur during dose initiation or escalation and often diminish over time as the body adjusts to the medication
Practical factorssuch as insurance coverage, approved indication (type 2 diabetes vs obesity), drug availability, previous side effects, and co-existing health conditionsusually matter more than subtle mechanistic differences when deciding which medication to use and how aggressively to dose it